![Yoshinari Kumagai](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yoshinari Kumagai
Vorstandsvorsitzender bei OrthoTrophix, Inc.
Aktive Positionen von Yoshinari Kumagai
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
OrthoTrophix, Inc.
![]() OrthoTrophix, Inc. Pharmaceuticals: MajorHealth Technology OrthoTrophix, Inc. is a privately held American biopharmaceutical company founded in 2011 by Dawn McGuire, Yoshinari Kumagai, and David M. Rosen. The company is based in the area and focuses on the development and commercialization of a first-in-class disease modifying osteoarthritis drug (DMOAD). Its primary focus has been regeneration and repair of cartilage and underlying bones in the knee and other joints with its novel proprietary compounds. Yoshinari Kumagai has been the CEO since 2011. | Vorstandsvorsitzender | 01.09.2011 | - |
Gründer | 01.05.2011 | - | |
Präsident | 01.09.2011 | - |
Karriereverlauf von Yoshinari Kumagai
Ehemalige bekannte Positionen von Yoshinari Kumagai
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Kirin-Amgen, Inc.
![]() Kirin-Amgen, Inc. Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Kirin-Amgen, Inc. is a pharmaceutical company that manufactures drugs and provides licensing. The company is based in Thousand Oaks, CA. Kirin-Amgen was acquired by Amgen, Inc. from Kirin Holdings Co., Ltd. on January 29, 2018 for $810 million. | Corporate Officer/Principal | - | - |
Acologix, Inc.
![]() Acologix, Inc. Pharmaceuticals: MajorHealth Technology Acologix, Inc. develops and commercializes medicines. The company was founded by Yoshinari Kumagai in 1992 and is headquartered in Hayward, CA. | Vorstandsvorsitzender | 01.01.1992 | - |
Gründer | 01.01.1992 | - | |
Präsident | 01.01.1992 | - |
Ausbildung von Yoshinari Kumagai
Waseda University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Japan | 2 |
Operativ
Chief Executive Officer | 2 |
Founder | 2 |
President | 2 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Acologix, Inc.
![]() Acologix, Inc. Pharmaceuticals: MajorHealth Technology Acologix, Inc. develops and commercializes medicines. The company was founded by Yoshinari Kumagai in 1992 and is headquartered in Hayward, CA. | Health Technology |
Kirin-Amgen, Inc.
![]() Kirin-Amgen, Inc. Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Kirin-Amgen, Inc. is a pharmaceutical company that manufactures drugs and provides licensing. The company is based in Thousand Oaks, CA. Kirin-Amgen was acquired by Amgen, Inc. from Kirin Holdings Co., Ltd. on January 29, 2018 for $810 million. | Health Technology |
OrthoTrophix, Inc.
![]() OrthoTrophix, Inc. Pharmaceuticals: MajorHealth Technology OrthoTrophix, Inc. is a privately held American biopharmaceutical company founded in 2011 by Dawn McGuire, Yoshinari Kumagai, and David M. Rosen. The company is based in the area and focuses on the development and commercialization of a first-in-class disease modifying osteoarthritis drug (DMOAD). Its primary focus has been regeneration and repair of cartilage and underlying bones in the knee and other joints with its novel proprietary compounds. Yoshinari Kumagai has been the CEO since 2011. | Health Technology |
- Börse
- Insiders
- Yoshinari Kumagai
- Erfahrung